For an estimated 2.4 million people in Ghana living with diabetes, a manageable chronic illness has become a desperate daily struggle for survival. By exploring Ghana’s diabetes crisis, we uncover how families become trapped in a devastating cycle. They must...
Mounting criticism labels South Africa’s controversial National Health Insurance (NHI) plan not as a lifeline for a broken system. Instead, critics see it as a meticulously planned manoeuvre to centralise control over a budget exceeding R1 trillion. Opponents argue...
Global health and climate experts have issued a stark warning: the escalating climate crisis is fuelling a parallel health emergency. Africa is at its epicentre. Devastating reports from The Lancet Countdown and the World Meteorological Organisation (WMO) reveal the...
A groundbreaking, twice-yearly injection for HIV prevention is hailed as a potential ‘game-changer’. However, it is at the centre of a fierce debate regarding affordability. Health activists worldwide implore its manufacturer, Gilead Sciences, to prevent a...
In a decision that could fundamentally reshape the fight against HIV, the US Food and Drug Administration (FDA) has given its approval to Gilead Sciences’ lenacapavir, a groundbreaking twice-yearly injection for preventing HIV infection in adults and...
